Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Familial hypercholesterolemia - heterozygous
0.070 Biomarker disease BEFREE Age (OR: 1.07; 95% CI: 1.03, 1.10), male sex (OR: 1.95; 95% CI: 1.68, 2.23), hypertension (OR: 2.11; 95% CI: 1.64, 2.58), diabetes (OR: 1.95; 95% CI: 1.33, 2.57), body mass index (OR: 1.04; 95% CI: 1.03, 1.05), smoking (OR: 1.71; 95% CI: 1.30, 2.12), elevated lipoprotein(a) (OR: 1.90; 95% CI: 1.10, 2.71), low high-density lipoprotein cholesterol (OR: 1.39; 95% CI: 1.24, 1.53), and a family history of CVD (OR: 1.83, 95% CI: 1.58, 2.07) were found to be significant CVD risk factors in FH. 30527766 2020
Familial hypercholesterolemia - heterozygous
0.070 Biomarker disease BEFREE Lipoprotein(a) as a risk factor for calcific aortic valvulopathy in heterozygous familial hypercholesterolemia. 30616181 2019
Familial hypercholesterolemia - heterozygous
0.070 Biomarker disease BEFREE Association between lipoprotein (a) and proprotein convertase substilisin/kexin type 9 in patients with heterozygous familial hypercholesterolemia: A case-control study. 29129821 2018
Familial hypercholesterolemia - heterozygous
0.070 Biomarker disease BEFREE Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia. 26340131 2015
Familial hypercholesterolemia - heterozygous
0.070 Biomarker disease BEFREE The aim of this study was to determine the relationship between lipoprotein(a) [Lp(a)] and cardiovascular disease (CVD) in a large cohort of patients with heterozygous familial hypercholesterolemia (FH). 24632281 2014
Familial hypercholesterolemia - heterozygous
0.070 Biomarker disease BEFREE Lipoprotein(a) is an independent risk factor for cardiovascular disease in heterozygous familial hypercholesterolemia. 16141286 2005
Familial hypercholesterolemia - heterozygous
0.070 AlteredExpression disease BEFREE LDL-apheresis in treatment of two patients with heterozygous familial hypercholesterolemia and extremely elevated lipoprotein (a) levels. 10159508 1995